Clinical Study

An Open-Label Study To Assess The Long-Term Safety And Efficacy Of An Investigational Medications In Patients With Major Depression

Posted Date: Jul 23, 2019

  • Investigator: Lesley Arnold
  • Specialties: Depression, Psychiatry/Psychology
  • Type of Study: Drug

The goal of this study is to evaluate the long-term safety and efficacy of an investigational medication in people with major depression. The study is open-label, which means that all participants will receive the medication for up to 12 months.


Male Or Female Individuals, Age 18 To 65, With Major Depression Who Have Completed A Previous Study Of The Investigational Medication.


Depression, Major Depression

For More Information:

Kerri Earles

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.